Stay updated on XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial
Sign up to get notified when there's something new on the XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial page.

Latest updates to the XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.5.0 was added and the previous revision v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history now shows a new version entry: Revision v3.4.3. The previous Revision v3.4.2 has been removed.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.4.2 was added to the history, updating the record's published version information. The deletions include the funding-lapse notice and the earlier revision entry (v3.4.1).SummaryDifference0.9%

- Check59 days agoChange DetectedA site-wide notice about government funding and operations has been added, and the history now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.9%

- Check66 days agoChange DetectedUI updates include a glossary toggle, green highlights for additions and red highlights for deletions in the history view, and an updated revision label to v3.4.0. These changes are focused on labeling and presentation rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check80 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) added and the previous v3.3.3 entry removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial page.